BRAMPTON, Ontario — Sales at Shoppers Drug Mart edged up for the fiscal 2016 fourth quarter and year, with front-end business hoisting comparable-store results.
Parent Loblaw Companies Ltd., Canada’s largest food and drug retailer, said Thursday that for the fourth quarter ended Dec. 31, Shopper Drug Mart’s sales totaled $3.056 billion (Canadian), up 2.7% from $2.975 billion a year earlier.
Revenue in the front end rose 2.1% to $1.695 billion from $1.660 billion in the year-ago quarter. In the pharmacy, sales grew 3.5% to $1.361 billion from $1.315 billion. Pharmacy represented 44.5% of overall drug retail sales for the 2016 quarter.
Same-store sales were up 3.4% year over year for the fourth quarter, reflecting increases of 4.1% in the front end and 2.5% in the pharmacy. Loblaw noted that drug retail same-store sales include a 0.6% lift from an extra selling day in the quarter because of the timing of New Year’s Day.
Prescription count advanced 5% overall in the fourth quarter and 4.5% on a comparable pharmacy basis.
For the full year, Shoppers Drug Mart’s sales came in at $12.209 billion, up 3.5% from $11.797 billion in 2015.
Front-of-store revenue climbed 3.6% to $6.479 billion in 2016 from $6.252 billion in the prior year. Pharmacy sales rose 3.3% year over year to $5.730 billion from $5.545 billion. For 2016, pharmacy accounted for 46.9% of total drug retail sales.
Comp-store sales at Shoppers Drug Mart grew 4% in 2016, including gains of 5% in the front end and 2.9% in the pharmacy. Prescriptions dispensed increased 3.8% for the year and were up 3.5% on a comparable pharmacy basis.
Drug retail represented 26.9% of Loblaw’s overall retail segment sales for 2016, which rose 2.1% to $45.384 billion. Fourth-quarter retail segment sales totaled $10.845 billion, up 2.3%.
Loblaw’s food retail sales increased nearly 2.1% year over year to $7.789 billion in the fourth quarter, with same-store sales inching up 1.1% for the period. Overall food retail sales for 2016 were $33.175 billion, up 1.5% from the previous year, while comp-store sales gained 1.9%.
“We continued to lower prices, delivering more value to consumers,” Loblaw Cos. chairman and chief executive officer Galen Weston said in a statement. “Our focus on our strategic framework and financial plan delivered solid financial performance in the fourth quarter,” he added, “and demonstrated the strength of our portfolio of businesses amidst a highly competitive food retail environnment, and pressures from health care reform.”
As of Dec. 31, Shoppers Drug Mart had 1,326 drug stores, compared with 1,313 a year earlier. Loblaw finished 2016 with 565 supermarkets, most with pharmacies, as well as 533 franchised food stores.
The post Shoppers Drug Mart closes year with sales gains appeared first on CDR – Chain Drug Review.